Susan Graf

Presidente presso FINCH THERAPEUTICS GROUP, INC.

Patrimonio netto: 374 $ in data 30/04/2024

52 anni

84 relazioni

Health Technology

Consumer Services

Health Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Ronald D. Gunn	M	63	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Arthur Kuan	M	34	CG ONCOLOGY, INC.	7 anni
Chris W. Shumway	M	58	FINCH THERAPEUTICS GROUP, INC.	4 anni
Elder Granger	M	70	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	2 anni
Victor Tong	M	41	CG ONCOLOGY, INC.	1 anni
Hong Fang Song	F	59	CG ONCOLOGY, INC.	9 anni
Ned Ruffin	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Jeffery Smisek	M	69	FINCH THERAPEUTICS GROUP, INC.	7 anni
James Mulé	M	72	CG ONCOLOGY, INC.	6 anni
Ambaw Bellete	M	54	CG ONCOLOGY, INC.	1 anni
Christian Lange	M	44	FINCH THERAPEUTICS GROUP, INC.	7 anni
Michael Wells	M	55	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Domenic J. Ferrante	M	58	FINCH THERAPEUTICS GROUP, INC.	5 anni
Leonard Post	M	72	CG ONCOLOGY, INC.	6 anni
Brian Liu	M	36	CG ONCOLOGY, INC.	2 anni
Matthew Nelson	M	-	FINCH THERAPEUTICS GROUP, INC.	3 anni
Randy Raisman	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Jim Lenehan	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Matthew Blischak	M	-	FINCH THERAPEUTICS GROUP, INC.	1 anni
Vijay Kasturi	M	57	CG ONCOLOGY, INC.	1 anni
Lance Thibault	M	58	FINCH THERAPEUTICS GROUP, INC.	1 anni
Sonia Timberlake	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Erin Graves	M	-	EPIZYME, INC.	7 anni
Michelle L. Rose	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Bing Kung	M	-	CG ONCOLOGY, INC.	-
Evan Bedil	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	3 anni
Swapnil Bhargava	M	-	CG ONCOLOGY, INC.	1 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Andrew Singer	M	53	EPIZYME, INC.	2 anni
Suzanne Fleming	F	63	EPIZYME, INC.	2 anni
Matthew Ros	M	57	EPIZYME, INC.	5 anni
Andrew Noh	M	-	FINCH THERAPEUTICS GROUP, INC.	4 anni
Mark Smith	M	37	FINCH THERAPEUTICS GROUP, INC.	6 anni
Marc Blaustein	M	61	FINCH THERAPEUTICS GROUP, INC.	2 anni
Francois Nader	M	67	NPS PHARMACEUTICALS, INC.	7 anni
Joseph Vittiglio	M	52	FINCH THERAPEUTICS GROUP, INC.	2 anni
Edward H. Stratemeier	M	75	NPS PHARMACEUTICALS, INC.	5 anni
Joseph Beaulieu	M	43	EPIZYME, INC.	5 anni
Christine Cvijic	F	46	NPS PHARMACEUTICALS, INC.	1 anni
Pedro Granadillo	M	77	NPS PHARMACEUTICALS, INC.	5 anni
Julie DiCarlo	F	-	EPIZYME, INC.	-
Brendan P. Rae	M	-	NPS PHARMACEUTICALS, INC.	1 anni
Zain Kassam	M	42	FINCH THERAPEUTICS GROUP, INC.	4 anni
Nicholas Haft	M	35	FINCH THERAPEUTICS GROUP, INC.	3 anni
Anne Marie Conway	F	-	FINCH THERAPEUTICS GROUP, INC.	-
Christine Mikail,	-	-	NPS PHARMACEUTICALS, INC.	1 anni
Samuel Hamood	M	56	FINCH THERAPEUTICS GROUP, INC.	-
Colin Broom	M	68	NPS PHARMACEUTICALS, INC.	6 anni
Roger Garceau	M	70	NPS PHARMACEUTICALS, INC.	7 anni
Michael Bonney	M	65	NPS PHARMACEUTICALS, INC.	10 anni
Tai Ching Ho	M	62	EPIZYME, INC.	3 anni
Kevin Conroy	M	58	EPIZYME, INC.	5 anni
Gregory Perry	M	63	FINCH THERAPEUTICS GROUP, INC.	4 anni
John F. Weidenbruch	M	63	EPIZYME, INC.	5 anni
Shefali Agarwal	M	50	EPIZYME, INC.	4 anni
Debra Silberg	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Vishal Kapoor	M	48	NPS PHARMACEUTICALS, INC.	1 anni
Andrea Edwards	F	-	EPIZYME, INC.	3 anni
Jason Fredette	M	-	EPIZYME, INC.	-
Chris Weidenmaier	M	-	FINCH THERAPEUTICS GROUP, INC.	-
John Bishop	M	62	EPIZYME, INC.	4 anni
David Rhodes	M	-	FINCH THERAPEUTICS GROUP, INC.	3 anni
Ralf H. Rosskamp	M	71	NPS PHARMACEUTICALS, INC.	2 anni
David Pugatch	M	-	FINCH THERAPEUTICS GROUP, INC.	2 anni
Robert Copeland	M	-	EPIZYME, INC.	9 anni
Bryan Gillis	M	-	FINCH THERAPEUTICS GROUP, INC.	1 anni
Zoran Zdraveski	M	54	EPIZYME, INC.	5 anni
Eric Pauwels	M	63	NPS PHARMACEUTICALS, INC.	4 anni
Marcio Souza	M	45	NPS PHARMACEUTICALS, INC.	2 anni
Alka Batycky	M	54	FINCH THERAPEUTICS GROUP, INC.	1 anni
Scott Wilhoit	M	61	NPS PHARMACEUTICALS, INC.	2 anni
Susan M. Mesco	F	-	NPS PHARMACEUTICALS, INC.	7 anni
Pierre Legault	M	63	NPS PHARMACEUTICALS, INC.	1 anni
Robin D. Friedman	F	-	NPS PHARMACEUTICALS, INC.	1 anni
Kenneth Bahrt	M	71	NPS PHARMACEUTICALS, INC.	1 anni
Luke Beshar	M	65	NPS PHARMACEUTICALS, INC.	8 anni
Ellen Rosenberg	F	61	NPS PHARMACEUTICALS, INC.	-
Alyssa Wyant	F	49	NPS PHARMACEUTICALS, INC.	3 anni
Pamela Strode	F	-	EPIZYME, INC.	3 anni
Glenn R. Melrose	M	68	NPS PHARMACEUTICALS, INC.	2 anni
Dhiren D'silva	M	-	NPS PHARMACEUTICALS, INC.	2 anni
Rebecca Cohen	F	-	EPIZYME, INC.	-
Patrik Florencio	M	-	NPS PHARMACEUTICALS, INC.	1 anni
Paul Firuta	M	58	NPS PHARMACEUTICALS, INC.	1 anni
Leah Neufeld	F	-	NPS PHARMACEUTICALS, INC.	1 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	84	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni

Borsa valori
Insiders
Susan Graf
Contatti personali